Ontology type: schema:ScholarlyArticle Open Access: True
2014-02-19
AUTHORSThomas Zeller, Iris Baumgartner, Dierk Scheinert, Marianne Brodmann, Marc Bosiers, Antonio Micari, Patrick Peeters, Frank Vermassen, Mario Landini
ABSTRACTBackgroundThe effectiveness and durability of endovascular revascularization therapies for chronic critical limb ischemia (CLI) are challenged by the extensive burden of infrapopliteal arterial disease and lesion-related characteristics (e.g., severe calcification, chronic total occlusions), which frequently result in poor clinical outcomes. While infrapopliteal vessel patency directly affects pain relief and wound healing, sustained patency and extravascular care both contribute to the ultimate “patient-centric” outcomes of functional limb preservation, mobility and quality of life (QoL).Methods/DesignIN.PACT DEEP is a 2:1 randomized controlled trial designed to assess the efficacy and safety of infrapopliteal arterial revascularization between the IN.PACT Amphirion™ paclitaxel drug-eluting balloon (IA-DEB) and standard balloon angioplasty (PTA) in patients with Rutherford Class 4-5-6 CLI.DiscussionThis multicenter trial has enrolled 358 patients at 13 European centers with independent angiographic core lab adjudication of the primary efficacy endpoint of target lesion late luminal loss (LLL) and clinically driven target lesion revascularization (TLR) in major amputation-free surviving patients through 12-months. An independent wound core lab will evaluate all ischemic wounds to assess the extent of healing and time to healing at 1, 6, and 12 months. A QoL questionnaire including a pain scale will assess changes from baseline scores through 12 months. A Clinical Events Committee and Data Safety Monitoring Board will adjudicate the composite primary safety endpoints of all-cause death, major amputation, and clinically driven TLR at 6 months and other trial endpoints and supervise patient safety throughout the study. All patients will be followed for 5 years. A literature review is presented of the current status of endovascular treatment of CLI with drug-eluting balloon and standard PTA. The rationale and design of the IN.PACT DEEP Trial are discussed. IN.PACT DEEP is a milestone, prospective, randomized, robust, independent core lab-adjudicated CLI trial that will evaluate the role of a new infrapopliteal revascularization technology, the IA-DEB, compared to PTA. It will assess the overall impact on infrapopliteal artery patency, limb salvage, wound healing, pain control, QoL, and patient mobility. The 1-year results of the adjudicated co-primary and secondary endpoints will be available in 2014.Trial registrationNCT00941733 More... »
PAGES63
http://scigraph.springernature.com/pub.10.1186/1745-6215-15-63
DOIhttp://dx.doi.org/10.1186/1745-6215-15-63
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1006112664
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/24552184
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Clinical Sciences",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Amputation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Angioplasty, Balloon",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cardiovascular Agents",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Clinical Protocols",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Coated Materials, Biocompatible",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Critical Illness",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Disability Evaluation",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Equipment Design",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Europe",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Ischemia",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Limb Salvage",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Lower Extremity",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Paclitaxel",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Pain Management",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Pain Measurement",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Popliteal Artery",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Prospective Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Quality of Life",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Research Design",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Severity of Illness Index",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Time Factors",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Treatment Outcome",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Vascular Access Devices",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Vascular Patency",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Wound Healing",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "the IN.PACT DEEP Trial Investigators, Germany",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Angiology, Universit\u00e4ts Herzzentrum Freiburg Bad Krozingen, Bad Krozingen, Germany",
"the IN.PACT DEEP Trial Investigators, Germany"
],
"type": "Organization"
},
"familyName": "Zeller",
"givenName": "Thomas",
"id": "sg:person.01306206724.74",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306206724.74"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Swiss Cardiovascular Center, Division of Angiology, University Hospital, Inselspital, Bern, Switzerland",
"id": "http://www.grid.ac/institutes/grid.411656.1",
"name": [
"Swiss Cardiovascular Center, Division of Angiology, University Hospital, Inselspital, Bern, Switzerland"
],
"type": "Organization"
},
"familyName": "Baumgartner",
"givenName": "Iris",
"id": "sg:person.01044755235.51",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044755235.51"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Center of Vascular Medicine, Park Hospital Leipzig, Leipzig, Germany",
"id": "http://www.grid.ac/institutes/grid.452684.9",
"name": [
"Center of Vascular Medicine, Park Hospital Leipzig, Leipzig, Germany"
],
"type": "Organization"
},
"familyName": "Scheinert",
"givenName": "Dierk",
"id": "sg:person.01230314120.98",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01230314120.98"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Angiology, Medical University Graz, Graz, Austria",
"id": "http://www.grid.ac/institutes/grid.11598.34",
"name": [
"Department of Angiology, Medical University Graz, Graz, Austria"
],
"type": "Organization"
},
"familyName": "Brodmann",
"givenName": "Marianne",
"id": "sg:person.01257405407.39",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257405407.39"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Vascular Surgery, A.Z. Sint-Blasius, Dendermonde, Belgium",
"id": "http://www.grid.ac/institutes/grid.420039.c",
"name": [
"Department of Vascular Surgery, A.Z. Sint-Blasius, Dendermonde, Belgium"
],
"type": "Organization"
},
"familyName": "Bosiers",
"givenName": "Marc",
"id": "sg:person.01226555721.35",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226555721.35"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Invasive Cardioangiology GVM Care and Research, Palermo, Italy",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Invasive Cardioangiology GVM Care and Research, Palermo, Italy"
],
"type": "Organization"
},
"familyName": "Micari",
"givenName": "Antonio",
"id": "sg:person.01146465013.32",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01146465013.32"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Cardiovascular & Thoracic Surgery, Imelda Hospital, Bonheiden, Belgium",
"id": "http://www.grid.ac/institutes/grid.414579.a",
"name": [
"Department of Cardiovascular & Thoracic Surgery, Imelda Hospital, Bonheiden, Belgium"
],
"type": "Organization"
},
"familyName": "Peeters",
"givenName": "Patrick",
"id": "sg:person.01001742021.73",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001742021.73"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Vascular Surgery, Ghent University Hospital, Ghent, Belgium",
"id": "http://www.grid.ac/institutes/grid.410566.0",
"name": [
"Department of Vascular Surgery, Ghent University Hospital, Ghent, Belgium"
],
"type": "Organization"
},
"familyName": "Vermassen",
"givenName": "Frank",
"id": "sg:person.01101174413.48",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101174413.48"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Department of Medical Affairs, Endovascular Therapies, Medtronic Cardiovascular, Santa Rosa, CA, USA",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Department of Medical Affairs, Endovascular Therapies, Medtronic Cardiovascular, Santa Rosa, CA, USA"
],
"type": "Organization"
},
"familyName": "Landini",
"givenName": "Mario",
"id": "sg:person.01326203146.13",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326203146.13"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/s00270-010-9881-3",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1052201180",
"https://doi.org/10.1007/s00270-010-9881-3"
],
"type": "CreativeWork"
}
],
"datePublished": "2014-02-19",
"datePublishedReg": "2014-02-19",
"description": "BackgroundThe effectiveness and durability of endovascular revascularization therapies for chronic critical limb ischemia (CLI) are challenged by the extensive burden of infrapopliteal arterial disease and lesion-related characteristics (e.g., severe calcification, chronic total occlusions), which frequently result in poor clinical outcomes. While infrapopliteal vessel patency directly affects pain relief and wound healing, sustained patency and extravascular care both contribute to the ultimate \u201cpatient-centric\u201d outcomes of functional limb preservation, mobility and quality of life (QoL).Methods/DesignIN.PACT DEEP is a 2:1 randomized controlled trial designed to assess the efficacy and safety of infrapopliteal arterial revascularization between the IN.PACT Amphirion\u2122 paclitaxel drug-eluting balloon (IA-DEB) and standard balloon angioplasty (PTA) in patients with Rutherford Class 4-5-6 CLI.DiscussionThis multicenter trial has enrolled 358 patients at 13 European centers with independent angiographic core lab adjudication of the primary efficacy endpoint of target lesion late luminal loss (LLL) and clinically driven target lesion revascularization (TLR) in major amputation-free surviving patients through 12-months. An independent wound core lab will evaluate all ischemic wounds to assess the extent of healing and time to healing at 1, 6, and 12\u00a0months. A QoL questionnaire including a pain scale will assess changes from baseline scores through 12\u00a0months. A Clinical Events Committee and Data Safety Monitoring Board will adjudicate the composite primary safety endpoints of all-cause death, major amputation, and clinically driven TLR at 6\u00a0months and other trial endpoints and supervise patient safety throughout the study. All patients will be followed for 5\u00a0years. A literature review is presented of the current status of endovascular treatment of CLI with drug-eluting balloon and standard PTA. The rationale and design of the IN.PACT DEEP Trial are discussed. IN.PACT DEEP is a milestone, prospective, randomized, robust, independent core lab-adjudicated CLI trial that will evaluate the role of a new infrapopliteal revascularization technology, the IA-DEB, compared to PTA. It will assess the overall impact on infrapopliteal artery patency, limb salvage, wound healing, pain control, QoL, and patient mobility. The 1-year results of the adjudicated co-primary and secondary endpoints will be available in 2014.Trial registrationNCT00941733",
"genre": "article",
"id": "sg:pub.10.1186/1745-6215-15-63",
"inLanguage": "en",
"isAccessibleForFree": true,
"isPartOf": [
{
"id": "sg:journal.1297400",
"issn": [
"1468-6708",
"1745-6215"
],
"name": "Trials",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "1",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "15"
}
],
"keywords": [
"chronic critical limb ischemia",
"target lesion revascularization",
"critical limb ischemia",
"drug-eluting balloons",
"PACT DEEP",
"limb ischemia",
"paclitaxel drug-eluting balloon",
"composite primary safety endpoint",
"standard percutaneous transluminal angioplasty",
"Data Safety Monitoring Board",
"lesion-related characteristics",
"functional limb preservation",
"infrapopliteal arterial revascularization",
"standard balloon angioplasty",
"Rutherford class 4",
"primary safety endpoint",
"primary efficacy endpoint",
"clinical events committee",
"late luminal loss",
"percutaneous transluminal angioplasty",
"infrapopliteal arterial disease",
"poor clinical outcome",
"endovascular revascularization therapy",
"wound healing",
"safety monitoring board",
"quality of life",
"arterial revascularization",
"lesion revascularization",
"surviving patients",
"cause death",
"major amputation",
"standard PTA",
"revascularization technologies",
"pain relief",
"efficacy endpoint",
"safety endpoint",
"pain control",
"secondary endpoints",
"pain scale",
"artery patency",
"transluminal angioplasty",
"revascularization therapy",
"limb preservation",
"multicenter trial",
"limb salvage",
"infrapopliteal revascularization",
"arterial disease",
"clinical outcomes",
"luminal loss",
"extent of healing",
"events committee",
"endovascular treatment",
"balloon angioplasty",
"QOL questionnaire",
"trial endpoints",
"vessel patency",
"ischemic wounds",
"extensive burden",
"monitoring board",
"baseline scores",
"patients",
"revascularization",
"core lab",
"patient safety",
"patency",
"patient mobility",
"trials",
"endpoint",
"months",
"healing",
"angioplasty",
"ischemia",
"balloon",
"class 4",
"outcomes",
"literature review",
"safety",
"QoL",
"amputation",
"therapy",
"salvage",
"disease",
"PTA",
"paclitaxel",
"care",
"rationale",
"efficacy",
"death",
"wounds",
"current status",
"treatment",
"burden",
"scores",
"relief",
"questionnaire",
"overall impact",
"status",
"European Centre",
"review",
"years",
"Committee",
"control",
"center",
"study",
"life",
"protocol",
"role",
"preservation",
"loss",
"changes",
"milestones",
"extent",
"quality",
"effectiveness",
"time",
"impact",
"scale",
"In",
"adjudication",
"results",
"characteristics",
"mobility",
"board",
"lab",
"design",
"durability",
"Deep",
"technology"
],
"name": "IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial",
"pagination": "63",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1006112664"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1186/1745-6215-15-63"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"24552184"
]
}
],
"sameAs": [
"https://doi.org/10.1186/1745-6215-15-63",
"https://app.dimensions.ai/details/publication/pub.1006112664"
],
"sdDataset": "articles",
"sdDatePublished": "2022-05-10T10:11",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220509/entities/gbq_results/article/article_636.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1186/1745-6215-15-63"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1745-6215-15-63'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1745-6215-15-63'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1745-6215-15-63'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1745-6215-15-63'
This table displays all metadata directly associated to this object as RDF triples.
377 TRIPLES
22 PREDICATES
181 URIs
172 LITERALS
33 BLANK NODES
Subject | Predicate | Object | |
---|---|---|---|
1 | sg:pub.10.1186/1745-6215-15-63 | schema:about | N04937f27adfb467eac76fe422e4e7c88 |
2 | ″ | ″ | N0e4e0eb7874846e9b7830a3d6cde3fd7 |
3 | ″ | ″ | N1a7732acd2dc4306a74a1eb0ef8e4306 |
4 | ″ | ″ | N24d6ea67da9f49e583f9002cefa3aa95 |
5 | ″ | ″ | N2a1344b763754166833167f265ecb2ef |
6 | ″ | ″ | N525dd8db369e4f68a5627aaf8d3ace75 |
7 | ″ | ″ | N678e6f28d74f460284a2a6263f554dfb |
8 | ″ | ″ | N7092f99937d04af187e9a49ee69b75e4 |
9 | ″ | ″ | N779a5fd019d04b268ec98c27586aeda9 |
10 | ″ | ″ | N78efdc56f2f44892a2f4b25b623d5c41 |
11 | ″ | ″ | N802cd03ae03349a5932b262a66350d91 |
12 | ″ | ″ | N8be7c43953484075959ff5d0d22221a7 |
13 | ″ | ″ | N9509fe765c984a1bbfac33906483ba3e |
14 | ″ | ″ | N9d463ba25eec457d84c47e13c25ad262 |
15 | ″ | ″ | Na22bdb2bf8ef4b5eafbfc89dfbece021 |
16 | ″ | ″ | Na3f78902a53d4233a05cdb8b00be9e26 |
17 | ″ | ″ | Na771238c51434aab89e992d906898470 |
18 | ″ | ″ | Nd72f86cc196848e8afb71ed84974d961 |
19 | ″ | ″ | Nd8321069b7ba47e6a35058793db9ff70 |
20 | ″ | ″ | Ne0bfbe3ffe9541ac9a235605c102070a |
21 | ″ | ″ | Ne2b7d18f6c114f10831350932afb18c6 |
22 | ″ | ″ | Ne6541479a3214c12b6a1d46ae9744d7c |
23 | ″ | ″ | Ne66a0555fae44648b10c2280206b7e11 |
24 | ″ | ″ | Nebb3344c96644e4e9e2142a51d73ee65 |
25 | ″ | ″ | Nee730c57a9c9413199b70b966c85bdd4 |
26 | ″ | ″ | Nf301be5c92a74351991faf9b563eff39 |
27 | ″ | ″ | anzsrc-for:11 |
28 | ″ | ″ | anzsrc-for:1103 |
29 | ″ | schema:author | N33319aeff440414d804529889e2592df |
30 | ″ | schema:citation | sg:pub.10.1007/s00270-010-9881-3 |
31 | ″ | schema:datePublished | 2014-02-19 |
32 | ″ | schema:datePublishedReg | 2014-02-19 |
33 | ″ | schema:description | BackgroundThe effectiveness and durability of endovascular revascularization therapies for chronic critical limb ischemia (CLI) are challenged by the extensive burden of infrapopliteal arterial disease and lesion-related characteristics (e.g., severe calcification, chronic total occlusions), which frequently result in poor clinical outcomes. While infrapopliteal vessel patency directly affects pain relief and wound healing, sustained patency and extravascular care both contribute to the ultimate “patient-centric” outcomes of functional limb preservation, mobility and quality of life (QoL).Methods/DesignIN.PACT DEEP is a 2:1 randomized controlled trial designed to assess the efficacy and safety of infrapopliteal arterial revascularization between the IN.PACT Amphirion™ paclitaxel drug-eluting balloon (IA-DEB) and standard balloon angioplasty (PTA) in patients with Rutherford Class 4-5-6 CLI.DiscussionThis multicenter trial has enrolled 358 patients at 13 European centers with independent angiographic core lab adjudication of the primary efficacy endpoint of target lesion late luminal loss (LLL) and clinically driven target lesion revascularization (TLR) in major amputation-free surviving patients through 12-months. An independent wound core lab will evaluate all ischemic wounds to assess the extent of healing and time to healing at 1, 6, and 12 months. A QoL questionnaire including a pain scale will assess changes from baseline scores through 12 months. A Clinical Events Committee and Data Safety Monitoring Board will adjudicate the composite primary safety endpoints of all-cause death, major amputation, and clinically driven TLR at 6 months and other trial endpoints and supervise patient safety throughout the study. All patients will be followed for 5 years. A literature review is presented of the current status of endovascular treatment of CLI with drug-eluting balloon and standard PTA. The rationale and design of the IN.PACT DEEP Trial are discussed. IN.PACT DEEP is a milestone, prospective, randomized, robust, independent core lab-adjudicated CLI trial that will evaluate the role of a new infrapopliteal revascularization technology, the IA-DEB, compared to PTA. It will assess the overall impact on infrapopliteal artery patency, limb salvage, wound healing, pain control, QoL, and patient mobility. The 1-year results of the adjudicated co-primary and secondary endpoints will be available in 2014.Trial registrationNCT00941733 |
34 | ″ | schema:genre | article |
35 | ″ | schema:inLanguage | en |
36 | ″ | schema:isAccessibleForFree | true |
37 | ″ | schema:isPartOf | Nd2922c6e409b402786efbd7d40be18a8 |
38 | ″ | ″ | Nd7e00857477a45799ad6bc93feb4606d |
39 | ″ | ″ | sg:journal.1297400 |
40 | ″ | schema:keywords | Committee |
41 | ″ | ″ | Data Safety Monitoring Board |
42 | ″ | ″ | Deep |
43 | ″ | ″ | European Centre |
44 | ″ | ″ | In |
45 | ″ | ″ | PACT DEEP |
46 | ″ | ″ | PTA |
47 | ″ | ″ | QOL questionnaire |
48 | ″ | ″ | QoL |
49 | ″ | ″ | Rutherford class 4 |
50 | ″ | ″ | adjudication |
51 | ″ | ″ | amputation |
52 | ″ | ″ | angioplasty |
53 | ″ | ″ | arterial disease |
54 | ″ | ″ | arterial revascularization |
55 | ″ | ″ | artery patency |
56 | ″ | ″ | balloon |
57 | ″ | ″ | balloon angioplasty |
58 | ″ | ″ | baseline scores |
59 | ″ | ″ | board |
60 | ″ | ″ | burden |
61 | ″ | ″ | care |
62 | ″ | ″ | cause death |
63 | ″ | ″ | center |
64 | ″ | ″ | changes |
65 | ″ | ″ | characteristics |
66 | ″ | ″ | chronic critical limb ischemia |
67 | ″ | ″ | class 4 |
68 | ″ | ″ | clinical events committee |
69 | ″ | ″ | clinical outcomes |
70 | ″ | ″ | composite primary safety endpoint |
71 | ″ | ″ | control |
72 | ″ | ″ | core lab |
73 | ″ | ″ | critical limb ischemia |
74 | ″ | ″ | current status |
75 | ″ | ″ | death |
76 | ″ | ″ | design |
77 | ″ | ″ | disease |
78 | ″ | ″ | drug-eluting balloons |
79 | ″ | ″ | durability |
80 | ″ | ″ | effectiveness |
81 | ″ | ″ | efficacy |
82 | ″ | ″ | efficacy endpoint |
83 | ″ | ″ | endovascular revascularization therapy |
84 | ″ | ″ | endovascular treatment |
85 | ″ | ″ | endpoint |
86 | ″ | ″ | events committee |
87 | ″ | ″ | extensive burden |
88 | ″ | ″ | extent |
89 | ″ | ″ | extent of healing |
90 | ″ | ″ | functional limb preservation |
91 | ″ | ″ | healing |
92 | ″ | ″ | impact |
93 | ″ | ″ | infrapopliteal arterial disease |
94 | ″ | ″ | infrapopliteal arterial revascularization |
95 | ″ | ″ | infrapopliteal revascularization |
96 | ″ | ″ | ischemia |
97 | ″ | ″ | ischemic wounds |
98 | ″ | ″ | lab |
99 | ″ | ″ | late luminal loss |
100 | ″ | ″ | lesion revascularization |
101 | ″ | ″ | lesion-related characteristics |
102 | ″ | ″ | life |
103 | ″ | ″ | limb ischemia |
104 | ″ | ″ | limb preservation |
105 | ″ | ″ | limb salvage |
106 | ″ | ″ | literature review |
107 | ″ | ″ | loss |
108 | ″ | ″ | luminal loss |
109 | ″ | ″ | major amputation |
110 | ″ | ″ | milestones |
111 | ″ | ″ | mobility |
112 | ″ | ″ | monitoring board |
113 | ″ | ″ | months |
114 | ″ | ″ | multicenter trial |
115 | ″ | ″ | outcomes |
116 | ″ | ″ | overall impact |
117 | ″ | ″ | paclitaxel |
118 | ″ | ″ | paclitaxel drug-eluting balloon |
119 | ″ | ″ | pain control |
120 | ″ | ″ | pain relief |
121 | ″ | ″ | pain scale |
122 | ″ | ″ | patency |
123 | ″ | ″ | patient mobility |
124 | ″ | ″ | patient safety |
125 | ″ | ″ | patients |
126 | ″ | ″ | percutaneous transluminal angioplasty |
127 | ″ | ″ | poor clinical outcome |
128 | ″ | ″ | preservation |
129 | ″ | ″ | primary efficacy endpoint |
130 | ″ | ″ | primary safety endpoint |
131 | ″ | ″ | protocol |
132 | ″ | ″ | quality |
133 | ″ | ″ | quality of life |
134 | ″ | ″ | questionnaire |
135 | ″ | ″ | rationale |
136 | ″ | ″ | relief |
137 | ″ | ″ | results |
138 | ″ | ″ | revascularization |
139 | ″ | ″ | revascularization technologies |
140 | ″ | ″ | revascularization therapy |
141 | ″ | ″ | review |
142 | ″ | ″ | role |
143 | ″ | ″ | safety |
144 | ″ | ″ | safety endpoint |
145 | ″ | ″ | safety monitoring board |
146 | ″ | ″ | salvage |
147 | ″ | ″ | scale |
148 | ″ | ″ | scores |
149 | ″ | ″ | secondary endpoints |
150 | ″ | ″ | standard PTA |
151 | ″ | ″ | standard balloon angioplasty |
152 | ″ | ″ | standard percutaneous transluminal angioplasty |
153 | ″ | ″ | status |
154 | ″ | ″ | study |
155 | ″ | ″ | surviving patients |
156 | ″ | ″ | target lesion revascularization |
157 | ″ | ″ | technology |
158 | ″ | ″ | therapy |
159 | ″ | ″ | time |
160 | ″ | ″ | transluminal angioplasty |
161 | ″ | ″ | treatment |
162 | ″ | ″ | trial endpoints |
163 | ″ | ″ | trials |
164 | ″ | ″ | vessel patency |
165 | ″ | ″ | wound healing |
166 | ″ | ″ | wounds |
167 | ″ | ″ | years |
168 | ″ | schema:name | IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial |
169 | ″ | schema:pagination | 63 |
170 | ″ | schema:productId | N367067367585421c951539ae6ae1db07 |
171 | ″ | ″ | N4972e2d5c55d43c79bf3dd44335994d2 |
172 | ″ | ″ | N6295f92b1c294fb3b6626149f4c82f30 |
173 | ″ | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1006112664 |
174 | ″ | ″ | https://doi.org/10.1186/1745-6215-15-63 |
175 | ″ | schema:sdDatePublished | 2022-05-10T10:11 |
176 | ″ | schema:sdLicense | https://scigraph.springernature.com/explorer/license/ |
177 | ″ | schema:sdPublisher | N8de45180ab6a469abdd146b960969718 |
178 | ″ | schema:url | https://doi.org/10.1186/1745-6215-15-63 |
179 | ″ | sgo:license | sg:explorer/license/ |
180 | ″ | sgo:sdDataset | articles |
181 | ″ | rdf:type | schema:ScholarlyArticle |
182 | N04937f27adfb467eac76fe422e4e7c88 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
183 | ″ | schema:name | Europe |
184 | ″ | rdf:type | schema:DefinedTerm |
185 | N0e4e0eb7874846e9b7830a3d6cde3fd7 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
186 | ″ | schema:name | Prospective Studies |
187 | ″ | rdf:type | schema:DefinedTerm |
188 | N1a7732acd2dc4306a74a1eb0ef8e4306 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
189 | ″ | schema:name | Pain Measurement |
190 | ″ | rdf:type | schema:DefinedTerm |
191 | N24d6ea67da9f49e583f9002cefa3aa95 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
192 | ″ | schema:name | Coated Materials, Biocompatible |
193 | ″ | rdf:type | schema:DefinedTerm |
194 | N2a1344b763754166833167f265ecb2ef | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
195 | ″ | schema:name | Vascular Patency |
196 | ″ | rdf:type | schema:DefinedTerm |
197 | N33319aeff440414d804529889e2592df | rdf:first | sg:person.01306206724.74 |
198 | ″ | rdf:rest | Ne1c661375d6049ad925f8beecf571e3a |
199 | N367067367585421c951539ae6ae1db07 | schema:name | dimensions_id |
200 | ″ | schema:value | pub.1006112664 |
201 | ″ | rdf:type | schema:PropertyValue |
202 | N4972e2d5c55d43c79bf3dd44335994d2 | schema:name | doi |
203 | ″ | schema:value | 10.1186/1745-6215-15-63 |
204 | ″ | rdf:type | schema:PropertyValue |
205 | N525dd8db369e4f68a5627aaf8d3ace75 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
206 | ″ | schema:name | Time Factors |
207 | ″ | rdf:type | schema:DefinedTerm |
208 | N569830c692e24c59b34c8e6e8b56bf7d | rdf:first | sg:person.01001742021.73 |
209 | ″ | rdf:rest | Nd38d48b17a0b44b792e927b3400daa11 |
210 | N6295f92b1c294fb3b6626149f4c82f30 | schema:name | pubmed_id |
211 | ″ | schema:value | 24552184 |
212 | ″ | rdf:type | schema:PropertyValue |
213 | N678e6f28d74f460284a2a6263f554dfb | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
214 | ″ | schema:name | Popliteal Artery |
215 | ″ | rdf:type | schema:DefinedTerm |
216 | N6b7eb49d9bae471a95833131dfff586a | rdf:first | sg:person.01326203146.13 |
217 | ″ | rdf:rest | rdf:nil |
218 | N7092f99937d04af187e9a49ee69b75e4 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
219 | ″ | schema:name | Pain Management |
220 | ″ | rdf:type | schema:DefinedTerm |
221 | N7272086dca7c405c9d6f526b95cdb75d | rdf:first | sg:person.01257405407.39 |
222 | ″ | rdf:rest | Ne897386823544972afc4d5a9039829a4 |
223 | N779a5fd019d04b268ec98c27586aeda9 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
224 | ″ | schema:name | Quality of Life |
225 | ″ | rdf:type | schema:DefinedTerm |
226 | N78efdc56f2f44892a2f4b25b623d5c41 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
227 | ″ | schema:name | Cardiovascular Agents |
228 | ″ | rdf:type | schema:DefinedTerm |
229 | N802cd03ae03349a5932b262a66350d91 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
230 | ″ | schema:name | Severity of Illness Index |
231 | ″ | rdf:type | schema:DefinedTerm |
232 | N8be7c43953484075959ff5d0d22221a7 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
233 | ″ | schema:name | Wound Healing |
234 | ″ | rdf:type | schema:DefinedTerm |
235 | N8de45180ab6a469abdd146b960969718 | schema:name | Springer Nature - SN SciGraph project |
236 | ″ | rdf:type | schema:Organization |
237 | N92447ca1f7af44ce925ee4df5818fd47 | rdf:first | sg:person.01146465013.32 |
238 | ″ | rdf:rest | N569830c692e24c59b34c8e6e8b56bf7d |
239 | N9509fe765c984a1bbfac33906483ba3e | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
240 | ″ | schema:name | Equipment Design |
241 | ″ | rdf:type | schema:DefinedTerm |
242 | N9d463ba25eec457d84c47e13c25ad262 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
243 | ″ | schema:name | Angioplasty, Balloon |
244 | ″ | rdf:type | schema:DefinedTerm |
245 | Na22bdb2bf8ef4b5eafbfc89dfbece021 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
246 | ″ | schema:name | Vascular Access Devices |
247 | ″ | rdf:type | schema:DefinedTerm |
248 | Na3f78902a53d4233a05cdb8b00be9e26 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
249 | ″ | schema:name | Critical Illness |
250 | ″ | rdf:type | schema:DefinedTerm |
251 | Na771238c51434aab89e992d906898470 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
252 | ″ | schema:name | Clinical Protocols |
253 | ″ | rdf:type | schema:DefinedTerm |
254 | Nd2922c6e409b402786efbd7d40be18a8 | schema:volumeNumber | 15 |
255 | ″ | rdf:type | schema:PublicationVolume |
256 | Nd38d48b17a0b44b792e927b3400daa11 | rdf:first | sg:person.01101174413.48 |
257 | ″ | rdf:rest | N6b7eb49d9bae471a95833131dfff586a |
258 | Nd72f86cc196848e8afb71ed84974d961 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
259 | ″ | schema:name | Paclitaxel |
260 | ″ | rdf:type | schema:DefinedTerm |
261 | Nd7bf23378bae4864887843f3801e7cce | rdf:first | sg:person.01230314120.98 |
262 | ″ | rdf:rest | N7272086dca7c405c9d6f526b95cdb75d |
263 | Nd7e00857477a45799ad6bc93feb4606d | schema:issueNumber | 1 |
264 | ″ | rdf:type | schema:PublicationIssue |
265 | Nd8321069b7ba47e6a35058793db9ff70 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
266 | ″ | schema:name | Limb Salvage |
267 | ″ | rdf:type | schema:DefinedTerm |
268 | Ne0bfbe3ffe9541ac9a235605c102070a | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
269 | ″ | schema:name | Amputation |
270 | ″ | rdf:type | schema:DefinedTerm |
271 | Ne1c661375d6049ad925f8beecf571e3a | rdf:first | sg:person.01044755235.51 |
272 | ″ | rdf:rest | Nd7bf23378bae4864887843f3801e7cce |
273 | Ne2b7d18f6c114f10831350932afb18c6 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
274 | ″ | schema:name | Research Design |
275 | ″ | rdf:type | schema:DefinedTerm |
276 | Ne6541479a3214c12b6a1d46ae9744d7c | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
277 | ″ | schema:name | Lower Extremity |
278 | ″ | rdf:type | schema:DefinedTerm |
279 | Ne66a0555fae44648b10c2280206b7e11 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
280 | ″ | schema:name | Treatment Outcome |
281 | ″ | rdf:type | schema:DefinedTerm |
282 | Ne897386823544972afc4d5a9039829a4 | rdf:first | sg:person.01226555721.35 |
283 | ″ | rdf:rest | N92447ca1f7af44ce925ee4df5818fd47 |
284 | Nebb3344c96644e4e9e2142a51d73ee65 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
285 | ″ | schema:name | Humans |
286 | ″ | rdf:type | schema:DefinedTerm |
287 | Nee730c57a9c9413199b70b966c85bdd4 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
288 | ″ | schema:name | Disability Evaluation |
289 | ″ | rdf:type | schema:DefinedTerm |
290 | Nf301be5c92a74351991faf9b563eff39 | schema:inDefinedTermSet | https://www.nlm.nih.gov/mesh/ |
291 | ″ | schema:name | Ischemia |
292 | ″ | rdf:type | schema:DefinedTerm |
293 | anzsrc-for:11 | schema:inDefinedTermSet | anzsrc-for: |
294 | ″ | schema:name | Medical and Health Sciences |
295 | ″ | rdf:type | schema:DefinedTerm |
296 | anzsrc-for:1103 | schema:inDefinedTermSet | anzsrc-for: |
297 | ″ | schema:name | Clinical Sciences |
298 | ″ | rdf:type | schema:DefinedTerm |
299 | sg:journal.1297400 | schema:issn | 1468-6708 |
300 | ″ | ″ | 1745-6215 |
301 | ″ | schema:name | Trials |
302 | ″ | schema:publisher | Springer Nature |
303 | ″ | rdf:type | schema:Periodical |
304 | sg:person.01001742021.73 | schema:affiliation | grid-institutes:grid.414579.a |
305 | ″ | schema:familyName | Peeters |
306 | ″ | schema:givenName | Patrick |
307 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01001742021.73 |
308 | ″ | rdf:type | schema:Person |
309 | sg:person.01044755235.51 | schema:affiliation | grid-institutes:grid.411656.1 |
310 | ″ | schema:familyName | Baumgartner |
311 | ″ | schema:givenName | Iris |
312 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01044755235.51 |
313 | ″ | rdf:type | schema:Person |
314 | sg:person.01101174413.48 | schema:affiliation | grid-institutes:grid.410566.0 |
315 | ″ | schema:familyName | Vermassen |
316 | ″ | schema:givenName | Frank |
317 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101174413.48 |
318 | ″ | rdf:type | schema:Person |
319 | sg:person.01146465013.32 | schema:affiliation | grid-institutes:None |
320 | ″ | schema:familyName | Micari |
321 | ″ | schema:givenName | Antonio |
322 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01146465013.32 |
323 | ″ | rdf:type | schema:Person |
324 | sg:person.01226555721.35 | schema:affiliation | grid-institutes:grid.420039.c |
325 | ″ | schema:familyName | Bosiers |
326 | ″ | schema:givenName | Marc |
327 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01226555721.35 |
328 | ″ | rdf:type | schema:Person |
329 | sg:person.01230314120.98 | schema:affiliation | grid-institutes:grid.452684.9 |
330 | ″ | schema:familyName | Scheinert |
331 | ″ | schema:givenName | Dierk |
332 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01230314120.98 |
333 | ″ | rdf:type | schema:Person |
334 | sg:person.01257405407.39 | schema:affiliation | grid-institutes:grid.11598.34 |
335 | ″ | schema:familyName | Brodmann |
336 | ″ | schema:givenName | Marianne |
337 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01257405407.39 |
338 | ″ | rdf:type | schema:Person |
339 | sg:person.01306206724.74 | schema:affiliation | grid-institutes:None |
340 | ″ | schema:familyName | Zeller |
341 | ″ | schema:givenName | Thomas |
342 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01306206724.74 |
343 | ″ | rdf:type | schema:Person |
344 | sg:person.01326203146.13 | schema:affiliation | grid-institutes:None |
345 | ″ | schema:familyName | Landini |
346 | ″ | schema:givenName | Mario |
347 | ″ | schema:sameAs | https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01326203146.13 |
348 | ″ | rdf:type | schema:Person |
349 | sg:pub.10.1007/s00270-010-9881-3 | schema:sameAs | https://app.dimensions.ai/details/publication/pub.1052201180 |
350 | ″ | ″ | https://doi.org/10.1007/s00270-010-9881-3 |
351 | ″ | rdf:type | schema:CreativeWork |
352 | grid-institutes:None | schema:alternateName | Department of Medical Affairs, Endovascular Therapies, Medtronic Cardiovascular, Santa Rosa, CA, USA |
353 | ″ | ″ | Invasive Cardioangiology GVM Care and Research, Palermo, Italy |
354 | ″ | ″ | the IN.PACT DEEP Trial Investigators, Germany |
355 | ″ | schema:name | Department of Angiology, Universitäts Herzzentrum Freiburg Bad Krozingen, Bad Krozingen, Germany |
356 | ″ | ″ | Department of Medical Affairs, Endovascular Therapies, Medtronic Cardiovascular, Santa Rosa, CA, USA |
357 | ″ | ″ | Invasive Cardioangiology GVM Care and Research, Palermo, Italy |
358 | ″ | ″ | the IN.PACT DEEP Trial Investigators, Germany |
359 | ″ | rdf:type | schema:Organization |
360 | grid-institutes:grid.11598.34 | schema:alternateName | Department of Angiology, Medical University Graz, Graz, Austria |
361 | ″ | schema:name | Department of Angiology, Medical University Graz, Graz, Austria |
362 | ″ | rdf:type | schema:Organization |
363 | grid-institutes:grid.410566.0 | schema:alternateName | Department of Vascular Surgery, Ghent University Hospital, Ghent, Belgium |
364 | ″ | schema:name | Department of Vascular Surgery, Ghent University Hospital, Ghent, Belgium |
365 | ″ | rdf:type | schema:Organization |
366 | grid-institutes:grid.411656.1 | schema:alternateName | Swiss Cardiovascular Center, Division of Angiology, University Hospital, Inselspital, Bern, Switzerland |
367 | ″ | schema:name | Swiss Cardiovascular Center, Division of Angiology, University Hospital, Inselspital, Bern, Switzerland |
368 | ″ | rdf:type | schema:Organization |
369 | grid-institutes:grid.414579.a | schema:alternateName | Department of Cardiovascular & Thoracic Surgery, Imelda Hospital, Bonheiden, Belgium |
370 | ″ | schema:name | Department of Cardiovascular & Thoracic Surgery, Imelda Hospital, Bonheiden, Belgium |
371 | ″ | rdf:type | schema:Organization |
372 | grid-institutes:grid.420039.c | schema:alternateName | Department of Vascular Surgery, A.Z. Sint-Blasius, Dendermonde, Belgium |
373 | ″ | schema:name | Department of Vascular Surgery, A.Z. Sint-Blasius, Dendermonde, Belgium |
374 | ″ | rdf:type | schema:Organization |
375 | grid-institutes:grid.452684.9 | schema:alternateName | Center of Vascular Medicine, Park Hospital Leipzig, Leipzig, Germany |
376 | ″ | schema:name | Center of Vascular Medicine, Park Hospital Leipzig, Leipzig, Germany |
377 | ″ | rdf:type | schema:Organization |